These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16312139)

  • 21. The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase.
    Khosravan R; Grabowski BA; Mayer MD; Wu JT; Joseph-Ridge N; Vernillet L
    J Clin Pharmacol; 2006 Jan; 46(1):88-102. PubMed ID: 16397288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gout management: let's get it right this time.
    Sundy JS
    Arthritis Rheum; 2008 Nov; 59(11):1535-7. PubMed ID: 18975368
    [No Abstract]   [Full Text] [Related]  

  • 23. Febuxostat, a nonpurine selective inhibitor of xanthine oxidase: a promising medical therapy for chronic heart failure?
    Gao LG; Yao XP; Zhang L; Wen D; Luo F; Zhou XL; Hui RT
    Chin Med J (Engl); 2010 Sep; 123(17):2471-4. PubMed ID: 21034568
    [No Abstract]   [Full Text] [Related]  

  • 24. International position paper on febuxostat.
    Jansen TL; Richette P; Perez-Ruiz F; Tausche AK; Guerne PA; Punzi L; Leeb B; Barskova V; Uhlig T; Pimentão J; Zimmermann-Górska I; Pascual E; Bardin T; Doherty M
    Clin Rheumatol; 2010 Aug; 29(8):835-40. PubMed ID: 20401506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new xanthine oxidase inhibitor: the uric acid reduction and additional efficacy in CKD patients.
    Ohya M; Shigematsu T
    Clin Exp Nephrol; 2014 Dec; 18(6):835-6. PubMed ID: 24871070
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of xanthine oxidase by benzothiazinone analogues.
    Sheu SY; Lin CY; Wu JD; Chiang HC
    Anticancer Res; 1999; 19(1A):119-23. PubMed ID: 10226532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HTS followed by NMR based counterscreening. Discovery and optimization of pyrimidones as reversible and competitive inhibitors of xanthine oxidase.
    Evenäs J; Edfeldt F; Lepistö M; Svitacheva N; Synnergren A; Lundquist B; Gränse M; Rönnholm A; Varga M; Wright J; Wei M; Yue S; Wang J; Li C; Li X; Chen G; Liao Y; Lv G; Tjörnebo A; Narjes F
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1315-21. PubMed ID: 24508129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cetilistat, a new lipase inhibitor for the treatment of obesity.
    Padwal R
    Curr Opin Investig Drugs; 2008 Apr; 9(4):414-21. PubMed ID: 18393108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.
    Biggers K; Scheinfeld N
    Curr Opin Investig Drugs; 2008 Apr; 9(4):422-9. PubMed ID: 18393109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed treatment effects of xanthine oxidase inhibition on systolic overload-induced left ventricular hypertrophy and dysfunction.
    Xu X; Zhao L; Hu X; Zhang P; Wessale J; Bache R; Chen Y
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):306-13. PubMed ID: 20544512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xanthine oxidase inhibitors: a patent survey.
    Kumar R; Darpan ; Sharma S; Singh R
    Expert Opin Ther Pat; 2011 Jul; 21(7):1071-108. PubMed ID: 21510722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.
    Schumacher HR; Becker MA; Lloyd E; MacDonald PA; Lademacher C
    Rheumatology (Oxford); 2009 Feb; 48(2):188-94. PubMed ID: 19141576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual and in vitro bioassay screening of phytochemical inhibitors from flavonoids and isoflavones against xanthine oxidase and cyclooxygenase-2 for gout treatment.
    Li Y; Frenz CM; Li Z; Chen M; Wang Y; Li F; Luo C; Sun J; bohlin L; Li Z; Yang H; Wang C
    Chem Biol Drug Des; 2013 Apr; 81(4):537-44. PubMed ID: 23534413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of xanthine oxidase inhibition by febuxostat on the pharmacokinetics of theophylline.
    Tsai M; Wu JT; Gunawardhana L; Naik H
    Int J Clin Pharmacol Ther; 2012 May; 50(5):331-7. PubMed ID: 22541837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors.
    Hsieh JF; Wu SH; Yang YL; Choong KF; Chen ST
    Bioorg Med Chem; 2007 May; 15(10):3450-6. PubMed ID: 17379526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of patents on anti-gout therapies issued in China.
    Yuan HY; Zhang XH; Zhang XL; Wei JF; Meng L
    Expert Opin Ther Pat; 2014 May; 24(5):555-72. PubMed ID: 24605811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Febuxostat provides new gout treatment option.
    Belavic JM
    Nurse Pract; 2010 Mar; 35(3):9-10. PubMed ID: 20164728
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia.
    Sánchez-Lozada LG; Tapia E; Soto V; Avila-Casado C; Franco M; Zhao L; Johnson RJ
    Nephrol Dial Transplant; 2008 Apr; 23(4):1179-85. PubMed ID: 18048425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
    Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
    J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.